Clinical Design Physician Neuroscience (M.D.)

Clinical Design Physician

At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve. This is hard, urgent, selfless workbut it's work worth doing. If you're driven by purpose and ready to bring your best to work that truly matters for patients, we invite you to join us.

Responsibilities

The primary responsibilities of the Clinical Design Physician are focused on the design of Phase II to Phase IV clinical programs and studies within the neuroscience therapeutic area. The core job responsibilities typically include those listed below as well as all other duties as assigned.

Clinical Plan and Trial Options and Clinical Trial Protocols

• As the Medical leader on a cross-functional Clinical Design team, translate therapeutic area and asset team strategy into clear objectives and associated clinical development program and trial optionality. Optionality will address business and customer needs (patient, prescriber, payer, and/or regulator); be in alignment with phase of product lifecycle; and clearly articulate associated tradeoffs in value (data generated, risks created/discharged, cost, and time).
• Represent program and trial design optionality to asset teams and Sr. Leaders to inform prioritization of an option that will be translated into a clinical protocol(s). Adjust optionality in accordance with feedback from leadership.
• Bring the medical/clinical perspective to the Design Team to inform the design of study protocols and in partnership with the other functions (e.g. Asset Team, BU Development Team).
• Provide insight into impact of study/protocol design features to feasibility, value, patient and investigator burden, and execution speed/efficiency.
• Contribute to the development of asset strategy (e.g., identification of target patient population) in partnership with the asset team.
• Contribute to business unit and global alignment of portfolio clinical strategy and the associated asset-specific clinical plans including main indication and line extensions.

Clinical Research/Trial Packages, Execution and Support

• Collaborate and complement clinical research staff in the design and conduct of clinical trials (e.g. sample size, patient commitment, timelines, grants, and governance review interactions).
• Understand how design elements influence the ability to deliver on new regulatory expectations (e.g. decentralization of clinical trials, increase racial and ethnic diversity in clinical trials) and clinical capabilities (e.g. value-based, patient accessibility, patient burden).
• Review risk profiles to ensure appropriate communication of risk to study subjects via the protocol.
• Support investigator identification and selection, in conjunction with Clinical Development.
• Partner with Clinical Development to accelerate participant recruitment and retention efforts especially considering how design elements can create value in these areas.
• Support seamless transition of protocols from design to execution.

Scientific Data Dissemination/Exchange

• Knowledge of and compliance with local laws and regulations, global policies and procedures, and compliance guidelines with respect to data dissemination and interactions with external health care professionals.
• Establish and maintain appropriate collaborations and relationships with external experts, thought leaders, and the general medical community.
• Develop and maintain appropriate collaborations and relationships with relevant professional societies, conferences, and consortia.
• Participate in development of scientific data dissemination and preparation of final reports and publications related to assets and/or support efforts to influence clinical design science within the industry.

Scientific / Technical Expertise

• Critically read, evaluate, and apply the relevant medical literature, status and data from competitive products, and updates with medical and other scientific developments relevant to the therapeutic area, disease state, and product.
• Be aware of current trends and projections for clinical research, practice, and access in the therapeutic area(s) relevant to the product.
• Engage appropriately with the asset teams and the business unit development teams on relevant external activities to have good understanding of their patients, medical and payer communities, and business strategy.
• Apply the above to the optionality recommended for clinical programs and trials and when supporting other medical-related areas as assigned.

Shared Learning

• Focus on organizational learning to proactively identify, apply, and share best practices and learnings related to program and protocol design within and outside the organization.
• Closely collaborate with asset teams and delivery teams to understand the impact of design on speed to protocol approval and study startup. Identify and participate in opportunities to analyze experience and improve approaches.
• Work closely with counterparts in Clinical Design and therapeutic areas to continue to evolve Lilly standards, tools, and best practices that span drug development.
• Provide clinical leadership in collaboration with other Clinical Design members in appropriate development of standardized/simplified processes, templates, and tools.

Basic Qualification Requirements:

• Medical Doctor or Doctor of Osteopathy. Must be board eligible or certified in relevant field or have completed the comparable level of post-medical school clinical training relevant to the country of hiring. US trained physicians must have achieved board eligibility or certification.
• Physicians trained outside the US who are not US board eligible or certified may be hired directly for employment in the US at the discretion of the Chief Medical Officer.
• Non-US trained physicians must have completed education and training at a medical school that meets the requirements of the Liaison Committee on Medical Education (LCME). For the recognized list of foreign medical schools and the disapproved list, see and .
• Pharmaceutical Industry experience or research experience of at least three (3) years that provides adequate background relevant to clinical trial design of PhII to Phase IV studies (e.g., designing clinical programs, trials, and/or protocols, statistical/inferential methods, rating instruments, regulatory standards, safety assessment, investigator/site management, decentralized clinical trials).

Additional Skills/Preferences:

• Board certification or eligibility within Neuroscience or related area strongly preferred.
• Clinical research experience in the therapeutic area.
• Strong understanding of therapeutic area pathology, pathophysiology, unmet needs, and treatment standards in major geographies (e.g. US, EU, Japan, China, etc).
• Strong foundation in statistical science, including Bayesian statistics, as applied to study design (e.g., sample size determination, setting of critical success factors). Ability to communicate effectively with statisticians and help translate complex principles to inform design optionality and protocols.
• Global / multi-national design or development experience.
• Willing to relocate to Indianapolis. If unable to relocate, demonstrated ability to work with high effectiveness from a remote location in a hybrid environment. Willing to travel for business-critical events and to develop a strong internal network.
• Willing to engage in limited domestic and international travel to the degree appropriate to support the business of the team.
• Fluent in English, with strong communication skills, verbal and written.
• Strong interpersonal, organizational, and negotiation skills.
• Ability to influence others (both cross-functionally and within the function) to advance objectives.
• Understanding of how design elements translate into delivery. Bias for simplifying, reducing burden, and creation of value through excellent design.
• Strong communication skills demonstrated in a variety of modalities (e.g. presentations, meetings, creation of protocols and regulatory documents) and with broad set of stakeholders (e.g. team leaders, Sr. Leader decision makers, medical and non-medical counterparts, thought leaders, investigators, regulators).
• Experience routinely using AI to accelerate deliverables.

Additional Information:

Primary internal interactions

• Clinical Design and Development teammates and leadership
• Clinical planning